The Biden administration has announced a new framework to enforce the government’s “march-in” rights to seize patents on drugs developed with taxpayer funding if it deems that their prices are unreasonably high. While the government has had these rights for decades thanks to the 1980 Bayh-Dole Act, it has not used them previously. Before the…